Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd.
Published October 8, 2014 · Recall initiated: May 5, 2014
Summary
FDA records drug Class I recall D-1613-2014, published October 8, 2014 and initiated May 5, 2014. Recalling firm: Eugene Oregon, Inc.; Status: Terminated; Reported quantity: 136 boxes; Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Eugene Oregon, Inc.
- Distributor
- To retailers in MD, TX, FL, PA, IL, NJ, IN, LA, WA, ME, SC
- Lot
- All lots
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAFRICAN BLACK ANT, 2800 mg, 6 capsules per box, produced by: Qinghan Hongwei Bioengineering Company, No. 158,October 8, 2014
- FDAMOJO RISEN, 650 mg, 2 capsule per pouch, Distributed by: Mojo Risen, LLC, Springville, UT 84663October 8, 2014
- FDACREON (pancrelipase) Delayed-Release Capsules, Lipase 24,000 USP Units, 250 Capsule Bottles, Rx Only. MarketedOctober 8, 2014
- FDADianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, 5000 mL Ambu-Flex IIOctober 8, 2014
- FDAZoledronic Acid Injection 5 mg per 100 mL (0.05 mg/mL), 100 mL single-use bag packaged in a foil overwrap, RxOctober 8, 2014
- FDADOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02.October 8, 2014
Questions about this recall
Was Black Ant, 2800 mg, four capsules per box, Manufacturer Qinghai Baojiantang Pharmaceutical Co., Ltd. recalled?
Yes. FDA published recall D-1613-2014 on October 8, 2014. Reported hazard: Marketed Without an Approved NDA/ANDA: Eugene FDA laboratory analyses determined they contain undeclared sildenafil.
What should I do if I have this product?
Voluntary: Firm initiated · Letter